De novo design of drug-binding proteins with predictable binding energy and specificity
Science · 05.04.2024 · 384 (6691) · 106-112
DOI: 10.1126/science.adl5364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 05.04.2024. Verfasst von Lei Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry & Cardiovascular Research Institute, University of California, San Francisco, CA 94158, USA. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Proteins, Protein Engineering, Pharmacophore. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The de novo design of small molecule–binding proteins has seen exciting recent progress; however, high-affinity binding and tunable specificity typically require laborious screening and optimization after computational design. We developed a computational procedure to design a protein that recognizes a common pharmacophore in a series of poly(ADP-ribose) polymerase–1 inhibitors. One of three designed proteins bound different inhibitors with affinities ranging from
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry & Cardiovascular Research Institute, University of California, San Francisco, CA 94158, USA.
- Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158, USA.
- Department of Chemistry, University of California, Riverside, CA 92521, USA.
- Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.
ORCID-Profile: Lei Lu, Xuxu Gou, Sophia K Tan, Samuel I Mann, Hyunjun Yang, Dimitrios Gazgalis, Jesús Valdiviezo, Hyunil Jo, Morgan E Diolaiti, Alan Ashworth, Nicholas F Polizzi, William F DeGrado
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Lu, L., Gou, X., Tan, S. K., Mann, S. I., Yang, H., Zhong, X., Gazgalis, D., Valdiviezo, J., Jo, H., Wu, Y., Diolaiti, M. E., Ashworth, A., Polizzi, N. F., & DeGrado, W. F. (2024). De novo design of drug-binding proteins with predictable binding energy and specificity. Science, 384(6691), 106-112. https://doi.org/10.1126/science.adl5364
Vancouver
Lu L, Gou X, Tan SK, Mann SI, Yang H, Zhong X, et al. De novo design of drug-binding proteins with predictable binding energy and specificity. Science. 2024;384(6691):106-112. doi:10.1126/science.adl5364
BibTeX
@article{Lu2024,
author = {Lu, Lei and Gou, Xuxu and Tan, Sophia K and Mann, Samuel I and Yang, Hyunjun and Zhong, Xiaofang and Gazgalis, Dimitrios and Valdiviezo, Jesús and Jo, Hyunil and Wu, Yibing and Diolaiti, Morgan E and Ashworth, Alan and Polizzi, Nicholas F and DeGrado, William F},
title = {De novo design of drug-binding proteins with predictable binding energy and specificity},
journal = {Science},
year = {2024},
volume = {384},
number = {6691},
pages = {106--112},
doi = {10.1126/science.adl5364}
}
EUVIMED